The patient has Levaquin 500 mg ordered once daily. The Levaquin is available in 100 mL of NS and should infuse over 1 hour. Using tubing with a 60 gtt/mL drop factor, how many drops per minute should the Levaquin be infused?

Choice A reason: Inhalation targets lungs; transdermal means skin absorption, not respiratory, and this route doesn’t match the prescribed method’s pharmacokinetic profile.

Choice B reason: Transdermal drugs absorb through skin layers; this delivers medication systemically via dermal capillaries, bypassing first-pass metabolism, as intended by the order.

Choice C reason: Rectal administration uses suppositories; transdermal is skin-based, not mucosal, and this route doesn’t align with the prescribed absorption method.

Choice D reason: Sublingual dissolves under the tongue; transdermal is cutaneous, not oral, and this differs entirely from the skin-based delivery system specified.

Choice A reason: While documentation and supervisor notification are crucial, immediate action involving the health care provider ensures timely response to potential adverse effects from the medication error.

Choice B reason: Relying solely on the absence of drug allergies is insufficient and may jeopardize patient safety. Errors require immediate communication and reporting for appropriate interventions.

Choice C reason: Timely provider notification prioritizes patient safety and enables corrective measures. Completing an incident report supports institutional transparency and learning to prevent future errors.

Choice D reason: Administering additional drugs risks compounding harm. The priority is addressing the initial error and ensuring patient safety without introducing further interventions.